Skip to main content
新赣江 logo

新赣江 — Investor Relations & Filings

Ticker · 920367 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2025-08-06 Governance Information
Country CN China
Listing Beijing Stock Exchange 920367

About 新赣江

http://www.xgjyy.com/

Jiangxi Xinganjiang Pharmaceutical Co., Ltd. specializes in the research, development, production, and distribution of a diverse range of pharmaceutical products. The company's portfolio encompasses chemical active pharmaceutical ingredients (APIs), chemical drug preparations, and traditional Chinese medicine (TCM) formulations. Its core product offerings target therapeutic areas such as cardiovascular and cerebrovascular health, digestive system disorders, and nutritional supplementation. Key products include Ginkgo Biloba extract, Vitamin C, and various gastrointestinal medications. By maintaining an integrated value chain that spans from raw material synthesis to finished dosage forms, the company ensures quality control and supply chain efficiency. It focuses on delivering high-quality healthcare solutions through continuous innovation in pharmaceutical manufacturing and formulation technology.

Recent filings

Filing Released Lang Actions
累积投票制实施细则
Governance Information Classification · 95% confidence The document is a detailed announcement of the implementation rules for cumulative voting system for the election of directors at Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It includes procedural rules, voting methods, and principles for director election. It is not a financial report, earnings release, or management discussion. It is not a notice of voting results but rather the internal governance rules related to board elections. The document is about governance practices and internal rules regarding director elections, which fits the Governance Information (CGR) category. The document length is 2857 characters, which is substantial and contains detailed governance content, not a brief announcement or certification. Therefore, the correct classification is CGR with high confidence.
2025-08-06 Chinese
对外投资管理制度
Governance Information Classification · 95% confidence The document is titled '江西新赣江药业股份有限公司对外投资管理制度' which translates to 'Jiangxi Xinganjiang Pharmaceutical Co., Ltd. External Investment Management System'. It details the company's internal policies and procedures regarding external investments, including decision-making authority, approval processes, financial management, and reporting requirements. The document includes references to board and shareholder meetings approving the policy but does not contain financial statements, earnings data, or audit results. It is a governance-related document outlining internal rules and management practices rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR). The document length is over 5,000 characters and is substantive, so it is not a mere announcement or regulatory filing.
2025-08-06 Chinese
总经理工作细则
Governance Information Classification · 95% confidence The document is titled as "江西新赣江药业股份有限公司总经理工作细则" which translates to "General Manager Work Rules of Jiangxi Xinganjiang Pharmaceutical Co., Ltd." It is a detailed internal management system document outlining the responsibilities, authority, and procedures related to the company's general manager and senior management. The document includes sections on the general manager's duties, decision-making authority, meeting procedures, reporting obligations, and performance evaluation. It is approved by the company's board of directors and is a governance-related internal regulation. There is no indication that this is a financial report, audit report, earnings release, or any other type of financial or regulatory filing. It is not an announcement of a report but the actual internal governance document. Therefore, the most appropriate classification is Governance Information (CGR). The document length (7210 characters) supports it being a full document rather than a brief announcement.
2025-08-06 Chinese
董事、高级管理人员离职管理制度
Board/Management Information Classification · 95% confidence The document is a detailed announcement regarding the establishment and approval of an internal management system specifically for the resignation and departure procedures of the company's directors and senior management. It includes voting results from a board meeting, detailed rules and obligations for directors and senior management upon leaving the company, and governance-related procedures. There is no financial data, earnings information, or report publication mentioned. The content focuses on board and management personnel policies and internal governance. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or policies related to the company's board or senior management.
2025-08-06 Chinese
内幕信息知情人登记管理制度
Regulatory Filings Classification · 95% confidence The document is a detailed internal management system regarding insider information registration and management for a listed company, including rules, responsibilities, and procedures related to insider information. It is not a financial report, earnings release, or announcement of voting results. It is a regulatory compliance document related to governance and internal controls. It does not fit into categories like Annual Report, Interim Report, or Audit Report. It is not a short announcement but a full policy document. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other categories.
2025-08-06 Chinese
内部审计制度
Audit Report / Information Classification · 95% confidence The document is titled as an internal audit system policy of Jiangxi Xinganjiang Pharmaceutical Co., Ltd., detailing the internal audit procedures, responsibilities, scope, and reporting mechanisms. It includes detailed internal audit rules, organizational structure, audit types, and reporting requirements. The document is not a financial report, earnings release, or announcement of voting results. It is a comprehensive internal audit policy document, which aligns with the category of Audit Report / Information (AR), as it relates to internal audit standards and procedures rather than a full annual report or a simple announcement. The document length (9496 characters) supports it being a substantive report rather than a brief announcement. Therefore, the classification is AR with high confidence. FY 2025
2025-08-06 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.